Literature DB >> 30284022

A novel liver retraction method in laparoscopic gastrectomy for gastric cancer.

Yuki Ushimaru1, Takeshi Omori2, Yoshiyuki Fujiwara1, Yuji Shishido1, Yoshitomo Yanagimoto1, Keijirou Sugimura1, Kazuyoshi Yamamoto1, Jeong-Ho Moon1, Hiroshi Miyata1, Masayuki Ohue1, Masahiko Yano1.   

Abstract

BACKGROUND: Retracting the lateral liver segment during laparoscopic distal gastrectomy is important for achieving an optimal surgical field. However, excessive force may injure the liver, causing temporary abnormalities of liver function tests after laparoscopic surgery. We developed a new liver retraction method and assessed its safety and utility. PATIENTS AND METHODS: We retrospectively analyzed records in our surgical database of consecutive surgical patients who underwent laparoscopic distal gastrectomy for early gastric cancer. We divided the 229 patients into two groups based on the liver retraction method used, either flexible liver retraction with clipping and suturing (FLICS) or the Nathanson retractor (NR). One-to-one propensity score matching was performed to match patients, resulting in the records of 53 pairs of cases extracted from the database. Operative and postoperative outcomes were assessed, including following the values of serum liver enzymes, total bilirubin, and C-reactive protein until postoperative day 30.
RESULTS: There were no significant differences in patient characteristics or preoperative data in the two groups. The retraction method was not changed intraoperatively for any patients. The operative time was significantly shorter in the FLICS group, but the amount of bleeding did not differ. Liver injury was not observed as a result of liver retraction during surgery. In both groups, serum liver enzymes temporarily increased after surgery but improved rapidly thereafter. The postoperative increases in aspartate transaminase, alanine transaminase, and C-reactive protein levels were significantly lower in the FLICS than in the NR group. No serious complications associated with liver retraction were observed in either group.
CONCLUSIONS: Our new liver retraction technique provided an optimal surgical field without inducing liver dysfunction. It is a simple, safe, and effective liver retraction technique.

Entities:  

Keywords:  Gastric cancer; Internal organ retractor; Laparoscopic gastrectomy; Liver retraction; Nathanson’s retractor; Propensity score-matched analysis

Mesh:

Year:  2018        PMID: 30284022     DOI: 10.1007/s00464-018-6461-0

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  4 in total

1.  Comparison of Two Types of Liver Retractors in Laparoscopic Roux-en-Y Gastric Bypass for Morbid Obesity.

Authors:  Sumit Midya; James Ramus; Aishah Hakim; Gregory Jones; Marianne Sampson
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

2.  Risk Factors for Postoperative Liver Enzyme Elevation After Laparoscopic Gastrectomy for Gastric Cancer.

Authors:  Akihiko Sano; Kana Saito; Kengo Kuriyama; Nobuhiro Nakazawa; Yasunari Ubukata; Keigo Hara; Makoto Sakai; Kyoichi Ogata; Takaharu Fukasawa; Makoto Sohda; Minoru Fukuchi; Hiroshi Naitoh; Ken Shirabe; Hiroshi Saeki
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

3.  Differential advantage of liver retraction methods in laparoscopic fundoplication for neurologically impaired patients: a comparison of three kinds of procedures.

Authors:  Toshio Harumatsu; Taichiro Nagai; Keisuke Yano; Shun Onishi; Koji Yamada; Waka Yamada; Makoto Matsukubo; Mitsuru Muto; Tatsuru Kaji; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2020-03-20       Impact factor: 1.827

4.  Is the 5-port approach necessary in laparoscopic gastrectomy? Comparison of surgical effects of reduced-port laparoscopic gastrectomy and conventional laparoscopic-assisted gastrectomy: A meta-analysis.

Authors:  Hao Lai; Zhen Yi; Di Long; Jungang Liu; Haiquan Qin; Xianwei Mo; Huage Zhong; Yuan Lin; Zhao Li
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.